Cell Signaling Technology develops and produces antibodies, ELISA kits, ChIP kits, proteomic kits, and other related reagents. Its products are used to study the cell signaling pathways that impact human health. The Company maintains an in-house research program, particularly in the area of cancer research, and has published scientific papers in many peer-reviewed journals.